Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Jul 3, 2019 · 10-Q · 33 days after period end · 0001144204-19-033793
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | $338.43K | -$13.34K |
| EPS Diluted | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended May 31, 2019 · filed Jul 3, 2019 · 33 d after period end
